Illumina Inc (ILMN) - Product Pipeline Analysis, 2025 Update

Summary

Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and cancer. The company’s portfolio encompasses sequencing kits and reagents; sequencing tools and systems; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing; microarray services; instrument services, training, and consulting. The company serves pharmaceutical companies, academic institutions, genomic research centers, biotechnology companies and clinical research organizations. The company sells its products through direct sales and distributors in the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Illumina Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Illumina Inc Company Overview
Illumina Inc Company Snapshot
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc – Pipeline Analysis Overview
Business Description
Illumina Inc - Key Facts
Illumina Inc - Major Products and Services
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Pipeline Products Overview
Companion Diagnostic Test - Brain Cancer
Companion Diagnostic Test - Brain Cancer Product Overview
Companion Diagnostic Test - Colorectal Cancer
Companion Diagnostic Test - Colorectal Cancer Product Overview
Companion Diagnostic Test - Head And Neck Squamous Cell Carcinoma
Companion Diagnostic Test - Head And Neck Squamous Cell Carcinoma Product Overview
Companion Diagnostic Test - Lung Cancer
Companion Diagnostic Test - Lung Cancer Product Overview
Companion Diagnostic Test - Melanoma
Companion Diagnostic Test - Melanoma Product Overview
Companion Diagnostic Test - Oncology
Companion Diagnostic Test - Oncology Product Overview
Companion Diagnostic Test - Prostate Cancer
Companion Diagnostic Test - Prostate Cancer Product Overview
Companion Diagnostic Test - Pseudomonas Aeruginosa Infection
Companion Diagnostic Test - Pseudomonas Aeruginosa Infection Product Overview
Diagnostic Test - Infectious Diseases
Diagnostic Test - Infectious Diseases Product Overview
Explify Test - CNS Infections
Explify Test - CNS Infections Product Overview
HRD CDx Test
HRD CDx Test Product Overview
InfiniumDx CytoSNP-12 Assay
InfiniumDx CytoSNP-12 Assay Product Overview
Integrated MiniSeq System
Integrated MiniSeq System Product Overview
Lab-On-A-Chip
Lab-On-A-Chip Product Overview
Long Read Human Whole Genome Assay
Long Read Human Whole Genome Assay Product Overview
LSD-100 Lysosomal Storage Enzyme Analyzer
LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview
MRSA Screening Test
MRSA Screening Test Product Overview
Multiplexed Diagnostic Device
Multiplexed Diagnostic Device Product Overview
NGS Diagnostic System
NGS Diagnostic System Product Overview
NGS-Based Transplant Diagnostic Assay
NGS-Based Transplant Diagnostic Assay Product Overview
NovaSeq 6000 Dx
Product Status
Novaseq Dx
Novaseq Dx Product Overview
Pipsenseq Assay
Pipsenseq Assay Product Overview
Point-Of-Care Diagnostic Device - HIV
Point-Of-Care Diagnostic Device - HIV Product Overview
Portable Benchtop Analyzer - Viral Load Assay
Portable Benchtop Analyzer - Viral Load Assay Product Overview
Prenatal Screening Test
Prenatal Screening Test Product Overview
TruSight NIPT
TruSight NIPT Product Overview
TruSight Oncology 500 - TP53 CDx Assay
TruSight Oncology 500 - TP53 CDx Assay Product Overview
TruSight Oncology 500 HRD
TruSight Oncology 500 HRD Product Overview
TruSight Oncology 500 HRD Clinical Trial
TruSight Tumor 170 CDx - LOXO-101
TruSight Tumor 170 CDx - LOXO-101 Product Overview
TruSight Tumor 170 CDx - LOXO-292
TruSight Tumor 170 CDx - LOXO-292 Product Overview
Verifi Prenatal Test
Verifi Prenatal Test Product Overview
Illumina Inc - Key Competitors
Illumina Inc - Key Employees
Illumina Inc - Key Employee Biographies
Illumina Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Illumina Inc, Recent Developments
May 30, 2025: Velsera Powers the Knowledgebase Behind Illumina’s Tso Comprehensive Test, Now Approved in Japan
May 29, 2025: Illumina Unveils PromoterAI, a Groundbreaking Algorithm to Accelerate Insights for Rare Disease Diagnosis
May 26, 2025: Illumina Comprehensive Genomic Profiling Test for Cancer Receives Regulatory Approval in Japan
May 13, 2025: Illumina DRAGEN v4.4 Powers Clinical Oncology Research and Multiomic Applications
May 01, 2025: Illumina and Ovation.io Launching First-Of-Kind GLP-1 Dataset To Accelerate New Therapy Development
Mar 19, 2025: Alliance for Genomic Discovery Completes 250000 Whole Genomes to Accelerate Drug Discovery
Mar 10, 2025: Illumina Addresses Recent Developments in China
Feb 21, 2025: Illumina Announces Collaboration With Broad Clinical Labs
Feb 19, 2025: Illumina Unveils First-Of-Its-Kind Spatial Transcriptomics Technology
Jan 13, 2025: NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Illumina Inc Pipeline Products and Ongoing Clinical Trials Overview
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Indication
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc, Key Facts
Illumina Inc, Major Products and Services
Illumina Inc Number of Pipeline Products by Development Stage
Illumina Inc Pipeline Products Summary by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status
Illumina Inc Ongoing Clinical Trials Summary
Companion Diagnostic Test - Brain Cancer - Product Status
Companion Diagnostic Test - Brain Cancer - Product Description
Companion Diagnostic Test - Colorectal Cancer - Product Status
Companion Diagnostic Test - Colorectal Cancer - Product Description
Companion Diagnostic Test - Head And Neck Squamous Cell Carcinoma - Product Status
Companion Diagnostic Test - Head And Neck Squamous Cell Carcinoma - Product Description
Companion Diagnostic Test - Lung Cancer - Product Status
Companion Diagnostic Test - Lung Cancer - Product Description
Companion Diagnostic Test - Melanoma - Product Status
Companion Diagnostic Test - Melanoma - Product Description
Companion Diagnostic Test - Oncology - Product Status
Companion Diagnostic Test - Oncology - Product Description
Companion Diagnostic Test - Prostate Cancer - Product Status
Companion Diagnostic Test - Prostate Cancer - Product Description
Companion Diagnostic Test - Pseudomonas Aeruginosa Infection - Product Status
Companion Diagnostic Test - Pseudomonas Aeruginosa Infection - Product Description
Diagnostic Test - Infectious Diseases - Product Status
Diagnostic Test - Infectious Diseases - Product Description
Explify Test - CNS Infections - Product Status
Explify Test - CNS Infections - Product Description
HRD CDx Test - Product Status
HRD CDx Test - Product Description
InfiniumDx CytoSNP-12 Assay - Product Status
InfiniumDx CytoSNP-12 Assay - Product Description
Integrated MiniSeq System - Product Status
Integrated MiniSeq System - Product Description
Lab-On-A-Chip - Product Status
Lab-On-A-Chip - Product Description
Long Read Human Whole Genome Assay - Product Status
Long Read Human Whole Genome Assay - Product Description
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
MRSA Screening Test - Product Status
MRSA Screening Test - Product Description
Multiplexed Diagnostic Device - Product Status
Multiplexed Diagnostic Device - Product Description
NGS Diagnostic System - Product Status
NGS Diagnostic System - Product Description
NGS-Based Transplant Diagnostic Assay - Product Status
NGS-Based Transplant Diagnostic Assay - Product Description
Product Status
NovaSeq 6000 Dx - Product Description
Novaseq Dx - Product Status
Novaseq Dx - Product Description
Pipsenseq Assay - Product Status
Pipsenseq Assay - Product Description
Point-Of-Care Diagnostic Device - HIV - Product Status
Point-Of-Care Diagnostic Device - HIV - Product Description
Portable Benchtop Analyzer - Viral Load Assay - Product Status
Portable Benchtop Analyzer - Viral Load Assay - Product Description
Prenatal Screening Test - Product Status
Prenatal Screening Test - Product Description
TruSight NIPT - Product Status
TruSight NIPT - Product Description
TruSight Oncology 500 - TP53 CDx Assay - Product Status
TruSight Oncology 500 - TP53 CDx Assay - Product Description
TruSight Oncology 500 HRD - Product Status
TruSight Oncology 500 HRD - Product Description
TruSight Oncology 500 HRD - Molecular Landscape Involved in the Onset of Breast Cancer in Patients With Germline BRCA-1/2 Mutations, During or After Therapy With Platinum-based Agents and/or PARP-inhibitors for Ovarian Cancer
TruSight Tumor 170 CDx - LOXO-101 - Product Status
TruSight Tumor 170 CDx - LOXO-101 - Product Description
TruSight Tumor 170 CDx - LOXO-292 - Product Status
TruSight Tumor 170 CDx - LOXO-292 - Product Description
Verifi Prenatal Test - Product Status
Verifi Prenatal Test - Product Description
Illumina Inc, Key Employees
Illumina Inc, Key Employee Biographies
Illumina Inc, Other Locations
Illumina Inc, Subsidiaries
Illumina Inc, Joint Venture
Glossary
List of Figures
Illumina Inc Pipeline Products by Equipment Type
Illumina Inc Pipeline Products by Development Stage
Illumina Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings